TY - JOUR
T1 - Hyperoxemia is Associated With Poor Neurological Outcomes in Patients With Out-of-Hospital Cardiac Arrest Rescued by Extracorporeal Cardiopulmonary Resuscitation
T2 - Insight From the Nationwide Multicenter Observational JAAM-OHCA (Japan Association for Acute Medicine) Registry
AU - Nishihara, Masaaki
AU - Hiasa, Ken ichi
AU - Enzan, Nobuyuki
AU - Ichimura, Kenzo
AU - Iyonaga, Takeshi
AU - Shono, Yuji
AU - Kashiura, Masahiro
AU - Moriya, Takashi
AU - Kitazono, Takanari
AU - Tsutsui, Hiroyuki
N1 - Funding Information:
This study was conducted on behalf of all the members and institutions of the JAAM-OHCA Registry. The participating institutions of the JAAM-OHCA Registry are listed at the following URL (http://www.jaamohca-web.com/list/). This registry was constructed based on the design, concept, and system of the CRITICAL Study in Osaka as well as “The establishment of data registry system for evaluating emergency medical decision regarding cardiovascular diseases (J‐ACUTE)”. This registry was supported by research funding from the JAAM and a scientific research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant 16K09034 and 15H05006) and the Ministry of Health, Labour, and Welfare of Japan (grant 25112601). Hiroyuki Tsutsui received honoraria from Otsuka, Takeda Pharmaceutical, Mitsubishi-Tanabe Pharma, Daiichi Sankyo, Nippon Boehringer Ingelheim, Bayer, Pfizer, Novartis Pharma, Ono Pharmaceutical, MSD, Teijin Pharma, and Bristol-Myers Squibb and Astellas Pharma; and received research funding from Nippon Boehringer Ingelheim, Mitsubishi-Tanabe Pharma, Japan Tobacco, Daiichi Sankyo, IQVIA Services Japan, Takeda Pharmaceutical, Bayer Yakuhin, Sanofi, Acterion Pharmaceuticals Japan, and MSD. The remaining authors disclose no conflicts.
Funding Information:
This registry was supported by research funding from the JAAM and a scientific research grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant 16K09034 and 15H05006) and the Ministry of Health, Labour, and Welfare of Japan (grant 25112601).
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/8
Y1 - 2022/8
N2 - Background: Previous studies have shown an association between hyperoxemia and mortality in patients with out-of-hospital cardiac arrest (OHCA) after cardiopulmonary resuscitation (CPR); however, evidence is lacking in the extracorporeal CPR (ECPR) setting. Objective: The aim of this study was to test the hypothesis that hyperoxemia is associated with poor neurological outcomes in patients treated by ECPR. Methods: The Japanese Association for Acute Medicine OHCA Registry is a multicenter, prospective, observational registry of patients from 2014 to 2017. Adult (18 years or older) patients who had undergone ECPR after OHCA were included. Eligible patients were divided into two groups based on the partial pressure of oxygen in arterial blood (PaO2) levels at 24 h after ECPR: the high-PaO2 group (n = 242) defined as PaO2 ≥ 157 mm Hg (median) and the low-PaO2 group (n = 211) defined as PaO2 60 to < 157 mm Hg. The primary outcome was the favorable neurological outcome, defined as a Cerebral Performance Categories Scale score of 1 to 2 at 30 days after OHCA. Results: Of 34,754 patients with OHCA, 453 patients were included. The neurological outcome was significantly lower in the high-PaO2 group than in the low-PaO2 group (15.9 vs. 33.5%; p < 0.001). After adjusting for potential confounders, high PaO2 was negatively associated with favorable neurological outcomes (adjusted odds ratio [aOR] 0.48; 95% confidence interval [CI] 0.24–0.97; p = 0.040). In a multivariate analysis with multiple imputation, high PaO2 was also negatively associated with favorable neurological outcomes (aOR 0.63; 95% CI 0.49–0.81; p < 0.001). Conclusions: Hyperoxemia was associated with worse neurological outcomes in OHCA patients with ECPR.
AB - Background: Previous studies have shown an association between hyperoxemia and mortality in patients with out-of-hospital cardiac arrest (OHCA) after cardiopulmonary resuscitation (CPR); however, evidence is lacking in the extracorporeal CPR (ECPR) setting. Objective: The aim of this study was to test the hypothesis that hyperoxemia is associated with poor neurological outcomes in patients treated by ECPR. Methods: The Japanese Association for Acute Medicine OHCA Registry is a multicenter, prospective, observational registry of patients from 2014 to 2017. Adult (18 years or older) patients who had undergone ECPR after OHCA were included. Eligible patients were divided into two groups based on the partial pressure of oxygen in arterial blood (PaO2) levels at 24 h after ECPR: the high-PaO2 group (n = 242) defined as PaO2 ≥ 157 mm Hg (median) and the low-PaO2 group (n = 211) defined as PaO2 60 to < 157 mm Hg. The primary outcome was the favorable neurological outcome, defined as a Cerebral Performance Categories Scale score of 1 to 2 at 30 days after OHCA. Results: Of 34,754 patients with OHCA, 453 patients were included. The neurological outcome was significantly lower in the high-PaO2 group than in the low-PaO2 group (15.9 vs. 33.5%; p < 0.001). After adjusting for potential confounders, high PaO2 was negatively associated with favorable neurological outcomes (adjusted odds ratio [aOR] 0.48; 95% confidence interval [CI] 0.24–0.97; p = 0.040). In a multivariate analysis with multiple imputation, high PaO2 was also negatively associated with favorable neurological outcomes (aOR 0.63; 95% CI 0.49–0.81; p < 0.001). Conclusions: Hyperoxemia was associated with worse neurological outcomes in OHCA patients with ECPR.
UR - http://www.scopus.com/inward/record.url?scp=85136738073&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85136738073&partnerID=8YFLogxK
U2 - 10.1016/j.jemermed.2022.05.018
DO - 10.1016/j.jemermed.2022.05.018
M3 - Article
C2 - 36038433
AN - SCOPUS:85136738073
SN - 0736-4679
VL - 63
SP - 221
EP - 231
JO - Journal of Emergency Medicine
JF - Journal of Emergency Medicine
IS - 2
ER -